Glycosylation of Methylflavonoids in the Cultures of Entomopathogenic Filamentous Fungi as a Tool for Obtaining New Biologically Active Compounds

Flavonoid compounds are secondary plant metabolites with numerous biological activities; they naturally occur mainly in the form of glycosides. The glucosyl moiety attached to the flavonoid core makes them more stable and water-soluble. The methyl derivatives of flavonoids also show increased stability and intestinal absorption. Our study showed that such flavonoids can be obtained by combined chemical and biotechnological methods with entomopathogenic filamentous fungi as glycosylation biocatalysts. In the current paper, two flavonoids, i.e., 2′-hydroxy-4-methylchalcone and 4′-methylflavone, have been synthesized and biotransformed in the cultures of two strains of entomopathogenic filamentous fungi Isaria fumosorosea KCH J2 and Beauveria bassiana KCH J1.5. Biotransformation of 2′-hydroxy-4-methylchalcone resulted in the formation of two dihydrochalcone glucopyranoside derivatives in the culture of I. fumosorosea KCH J2 and chalcone glucopyranoside derivative in the case of B. bassiana KCH J1.5. 4′-Methylflavone was transformed in the culture of I. fumosorosea KCH J2 into four products, i.e., 4′-hydroxymethylflavone, flavone 4′-methylene-O-β-d-(4″-O-methyl)-glucopyranoside, flavone 4′-carboxylic acid, and 4′-methylflavone 3-O-β-d-(4″-O-methyl)-glucopyranoside. 4′-Methylflavone was not efficiently biotransformed in the culture of B. bassiana KCH J1.5. The computer-aided simulations based on the chemical structures of the obtained compounds showed their improved physicochemical properties and antimicrobial, anticarcinogenic, hepatoprotective, and cardioprotective potential.


Introduction
Flavonoids are a large group of polyphenolic secondary metabolites of plants that exhibit extensive bioactive benefits, such as antiviral, antibacterial, anti-inflammatory, cardioprotective, hepatoprotective, skin senescence preventive and treatment, and anticarcinogenic [1][2][3][4][5][6][7][8][9] properties. With regard to their antiviral activity, flavonoids act at different stages of viral infection, including entrance, replication, and translation of viral proteins. They may be effective against many viruses, including influenza, human immunodeficiency virus (HIV), severe acute respiratory syndrome (SARS), and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) [8,9]. A comparison of the inhibitory concentration of flavonoids and standard antiviral compounds showed that flavonoids, such as baicalein and apigenin (flavones), and quercetin and fisetin (flavonols), exhibited similar or even greater activity than currently used drugs [8,9]. Concerning the cardioprotective activity of flavonoids, this is supported by both mechanistic and epidemiologic evidence, which suggests that a diet rich in flavonoids may be beneficial in reducing the risk of cardiovascular disease [7,10].
The extraction of flavonoids from plants does not meet the current quantitative requirements. The application of chemical synthesis is also not sufficient for the production of flavonoid glycosides because of low stereo and regioselectivity and drastic reaction conditions resulting in the decomposition of flavonoid aglycones. To achieve better results, enzymatic reactions using glycosyltransferases and also glucosyltransferase-methyltransferase functional modules have been applied [22][23][24]. Such reactions can be carried out as wholecell biotransformation, in vivo total biosynthesis, and in vitro enzymatic reaction [22][23][24][25][26][27]. Among these methods, the whole-cell biotransformation of flavonoid aglycones is promising because of its simplicity and low cost.
The primary goal of the presented study was to investigate the ability of two entomopathogenic filamentous fungi strains, i.e., Isaria fumosorosea KCH J2 and Beauveria bassiana KCH J1.5, to glycosylate 2 -hydroxy-4-methylchalcone and 4 -methyflavone, and to evaluate the potential biological activity of the obtained derivatives using in silico methods. The used strains had been employed in the glycosylation reactions described in our previous studies [25,[28][29][30][31][32][33]. The biotransformation substrates were obtained by our team in a two-step synthesis described in our earlier work [34].

Results and Discussion
The application of entomopathogenic filamentous fungi as biocatalysts in the transformation of 2 -hydroxy-4-methylchalcone and 4 -methylflavone in the cultures of I. fumosorosea KCH J2 and B. bassiana KCH J1.5 resulted in the formation of five new flavonoid glycosides. The products of the biotransformations were isolated and purified using the preparative thin-layer chromatography (TLC). The chemical structures of the biotransformation products were established based on the Nuclear Magnetic Resonance (NMR) spectroscopy and Liquid Chromatography-Mass Spectrometry (LC-MS). The structures of products 3a-3b were determined based on NMR spectroscopy (Tables 1 and 2, Schemes 3 and 4 showing key COSY (Correlation Spectroscopy) and HMBC (Heteronuclear Multiple Bond Coherence) correlations). In product 3a, the presence of a glucose moiety was confirmed by five characteristic carbon signals observed in the region from δ = 80.4 to δ = 62.3 ppm in the 13 C-NMR spectrum (Carbon-13 Nuclear Magnetic Resonance) (Supplementary Materials: Figure S27), as well as proton signals of δ H ranging from δ = 3.84 to δ = 3.15 ppm in the 1 H-NMR spectrum (Proton Nuclear Magnetic Resonance) (Supplementary Materials: Figure S24). In the 1 H-NMR spectrum, a one-proton doublet from the proton at the anomeric carbon atom was present at δ = 4.83 ppm with the coupling constant (J = 7.8 Hz), evidencing β-configuration of the glucose (Supplementary Materials: Figure S24). The glucose molecule was also O-methylated at C-4 because in the 1 H-NMR spectrum, a three-proton singlet at δ = 3.55 ppm, with the corresponding signal at δ = 60.6 ppm in the 13 C-NMR spectra, was observed (Supplementary Materials: Figures S24 and S27). Moreover, this moiety was correlated with the signal of C-4 (δ = 80.4 ppm) in the HMBC experiment, which evidences the position of the substitution with the -O-CH 3 group in the glucose unit (Supplementary Materials: Figure S38). In product 3a, the reduction of a double bond between C-α and C-β occurred and caused the shift of the protons at C-α from 7.93 (in 3) to 3.42 ppm (in 3a) and the protons at C-β from 8.02 (in 3) to 3.00 ppm (in 3a) (Supplementary Materials: Figures S3 and S24). Naturally, shifted protons at C-α and C-β were correlated with the carbonyl group and the C-1 signal in the HMBC experiment (Supplementary Materials: Figure S40). The signals from one proton of the hydroxyl group at C-2 and three protons of the methyl group at C-4 remained intact. The 4 -O-methylglucopyranoside was attached at C-5 because in the HMBC experiment, signals from shifted protons at C-3 (δ = 6.87 ppm) and C-6 (δ = 7.64 ppm) correlated with the shifted signal from C-5 (δ = 150.8 ppm). Moreover, the proton at the anomeric carbon atom (δ = 4.83 ppm) also correlated with the shifted signal from C-5 (δ = 150.8 ppm) (Supplementary Materials: Figures S37 and S39).  In the case of product 3b, the presence of a glucose moiety was also confirmed by five characteristic carbon signals observed in the region from δ = 80.1 to δ = 62.1 ppm in the 13 C-NMR spectrum (Supplementary Materials: Figure S52), as well as proton signals of δ H ranging from δ = 3.84 to δ = 3.21 ppm in the 1 H-NMR spectrum (Supplementary Materials: Figure S49). The presence of a proton at the anomeric carbon atom at δ = 5.06 ppm with the coupling constant (J = 7.8 Hz) confirmed the β-configuration of the glucose unit in the 1 H NMR spectrum (Supplementary Materials: Figure S49). O-methylation of the glucose unit at C-4 was established in the HMBC experiment by correlation of the signal from a three-proton singlet at δ = 3.56 ppm, with the corresponding signal at δ = 60.6 ppm in the 13 C-NMR spectrum and the signal of C-4 (δ = 80.1 ppm) (Supplementary Materials: Figure S61). Similar to product 3a, the reduction of a double bond between C-α and C-β also occurred and caused the shift of the protons at C-α from 7.93 (in 3) to 3.41 ppm (in 3b) and the protons at C-β from 8.02 (in 3) to 2.97 ppm (in 3b) (Supplementary Materials: Figures S3 and S49). In the HMBC experiment, the shifted protons at C-α and C-β correlated with the carbonyl group and with C-1 (Supplementary Materials: Figures S63 and S64). In this case, the signal from three protons of the methyl group at C-4 disappeared because the C-4-CH 3 group was hydroxylated. Two new signals appeared in the 1 H NMR spectrum, one from the methylene group at C-4 at δ = 4.58 ppm (J = 5.7 Hz) and the second one from the hydroxyl group attached to this methylene group at δ = 4.08 ppm (J = 5.8 Hz) (Supplementary Materials: Figure S49). In the HMBC experiment, the correlation between the protons at C-4-CH 2 -(δ = 4.58 ppm) and the signal from C-2 and C-6 (δ = 127.6 ppm) along with the correlation between the proton of the hydroxyl group at C-4-CH 2 -OH (δ = 4.08 ppm) and C-4 (δ = 141.2 ppm) confirmed the hydroxylation of the methyl group at C-4 (Supplementary Materials: Figure S63). The absence of the signal from one proton of the hydroxyl group at C-2 pointed out that glycosylation occurred at this position. Moreover, in the HMBC experiment, signals from shifted protons at C-3 (δ = 7.29 ppm) and C-6 (δ = 7.57 ppm) correlated with the shifted signal from C-2 (δ = 157.1 ppm) and the proton at the anomeric carbon atom (δ = 5.06 ppm) also correlated with the shifted signal from C-2 (δ = 157.    The structure of product 3c was also determined based on NMR spectroscopy (Tables 1 and 2, Scheme 6 showing key COSY and HMBC correlations). Like in the cases of the products 3a and 3b, in the 1 H NMR and 13 C NMR, characteristic signals from the protons and carbons of the glucose unit were observed (Supplementary Materials: Figures S73 and S76). Furthermore, the attachment of this glucose unit to substrate 3 was confirmed by the presence of a one-proton doublet from the proton at the anomeric carbon atom at δ = 4.92 ppm in the 1 H-NMR spectrum with the characteristic coupling constant (J = 7.8 Hz) typical for its β-configuration (Supplementary Materials: Figure S73). The O-methylation of the glucose unit at C-4 was confirmed in the HMBC experiment by correlation of the signal from a three-proton singlet at δ = 3.57 ppm (with the corresponding signal at δ = 60.6 ppm in the 13 C-NMR spectrum) and the signal of C-4 (δ = 80.6 ppm) (Supplementary Materials: Figure S86). Unlike products 3a and 3b, the double bond between C-α and C-β was not reduced in the case of product 3c. The signal from one proton of the hydroxyl group at C-2 remained intact. However, the signal from three protons of the methyl group at C-4 disappeared because the C-4-CH 3 group was hydroxylated, the same as in the case of product 3b. Two new signals appeared in the 1 H NMR spectrum, one from the methylene group at C-4 at δ = 4.70 ppm and the second one from the hydroxyl group attached to this methylene group at δ = 4.39 ppm (Supplementary Materials: Figure S73. The correlation between the protons at C-4-CH 2 -(δ = 4.70 ppm) and the signal from C-3 and C-5 (δ = 127.8 ppm) confirmed the hydroxylation of the methyl group at C-4 (Supplementary Materials: Figure S87). The 4 -O-methyl-glucopyranoside was attached at C-5 , the same as in the case of the product 3a, because in the HMBC experiment, the signals from shifted protons at C-3 (δ = 6.92 ppm) and C-6 (δ = 7.91 ppm) correlated with the shifted signal from C-5 (δ = 150.9 ppm). Furthermore, the proton at the anomeric carbon atom (δ = 4.92 ppm) also correlated with the shifted signal from C-5 (δ = 150.9 ppm) (Supplementary Materials: Figures S85 and S87). Our previous and other teams' studies showed that entomopathogenic filamentous fungi can be a valuable tool in the biotransformation of phenolic compounds, especially flavonoids, including 4 -O-methylglucosylation and hydroxylation [23,25,[28][29][30][31][35][36][37].

Biotransformation of 4 -Methylflavone
The second biotransformation product, 5b, was the O-methylglycosylated 4 -methylflavone derivative (Tables 3 and 4, Scheme 9 with key COSY and HMBC correlations). Like in the cases of the products 3a-3c, characteristic signals from the protons and carbons of the glucose moiety were observed in the 1 H NMR and 13 C NMR spectra (Supplementary Materials: Figures S133 and S136). The attachment of a glucose unit to substrate 5 was confirmed by the presence of a one-proton doublet from the proton at the anomeric carbon atom at δ = 4.42 ppm in the 1 H-NMR spectrum with the characteristic coupling constant (J = 7.8 Hz) for its β-configuration (Supplementary Materials: Figure S133). A threeproton singlet at δ = 3.54 ppm in the 1 H NMR spectrum with the corresponding signal at δ = 60.5 ppm in the 13 C-NMR spectrum evidenced the appearance of a -OCH 3 moiety (Supplementary Materials: Figures S133 and S136). Moreover, the correlation of this signal with the C-4 signal at δ 80.5 ppm confirmed that O-methylation occurred at the C-4 hydroxyl group of the sugar moiety (Supplementary Materials: Figure S146). The appearance in the 1 H NMR spectrum of two one-proton signals from the methylene moiety at δ = 5.00 and δ = 4.76 ppm instead of a three-proton signal from the methyl group at 2.43 ppm of substrate 5 evidenced the substitution at C-4 -CH 3 (Supplementary Materials: Figure S133). The presence of the characteristic AA'BB' coupling system with the signals from protons at C-2 and C-6 and signals from protons at C-3 and C-5 only slightly shifted confirmed substitution at C-4 -CH 3 (Supplementary Materials: Figure S132). In the HMBC experiment, a proton at the anomeric carbon atom (δ = 4.42 ppm) was visibly coupled with the C-4 -CH 2 -signal (δ = 70.3 ppm), proving substitution with the glucose unit at this position (Supplementary Materials: Figure S146). The product 5c was flavone 4 -carboxylic acid that probably arose as a product of further oxidation of the hydroxyl group attached at C-4 -CH 3 (Tables 3 and 4, Scheme 10 with key COSY and HMBC correlations). In the 1 H NMR spectrum, the signal from the 4methyl group at δ = 2.43 ppm was absent (Supplementary Materials: Figures S94 and S153). In addition, the signal of two protons at C-3 and C-5 was shifted strongly towards the lower field from δ = 7.41 (in 5) to δ = 8.23 ppm (in 5c) (Supplementary Materials: Figures S95 and S154). Likewise, the signal of two protons at C-2 and C-6 was also shifted strongly towards the lower field from δ = 7.99 (in 5) to δ = 8.26 ppm (in 5c) (Supplementary Materials: Figures S95 and S154). In the 13 C NMR spectrum, the signal of C-4 was shifted from δ = 143.1 (in 5) to δ = 134.0 ppm (in 5a), and the signal of C-4 -CH 3 disappeared (Supplementary Materials: Figures S96 and S156). In the 1 H NMR spectrum, the new signal appeared at δ = 166.9 ppm and correlated with the protons at C-3 and C-5 in the HMBC experiment. This signal was from the carboxylic group at C-4 (Supplementary Materials: Figure S162). This unique structure of the biotransformation product was confirmed by MS analysis (Supplementary Materials: Figure S152).  Tables 3 and 4, Scheme 11 with key COSY and HMBC correlations). In this case, the methyl group at C-4 remained intact, and the substitution with the glycosidic moiety occurred at C-3 because, in the 1 H NMR spectrum, the signal from the proton at C-3 disappeared (Supplementary Materials: Figures S94 and S169). The characteristic signals from the protons H2 -H6 appeared in the 1 H NMR spectrum (from about δ = 3.6 to about δ = 3.1 ppm, Supplementary Materials: Figure S171), as well as the corresponding carbon signals in the 13 C-NMR spectrum (from about δ = 80 ppm to about δ = 62 ppm, Supplementary Materials: Figure S174). The O-methylation, which occurred at the C-4 hydroxyl group of the sugar moiety, was confirmed because a three-proton singlet at δ = 3.51 ppm in the 1 H NMR with the corresponding signal at δ = 60.5 ppm in the 13 C-NMR spectra correlated with the signal of C-4 (about δ = 80 ppm) in the HMBC experiment (Supplementary Materials: Figure S183). The signal from H-1 at the anomeric carbon atom (at δ = 5.22 ppm in the 1 H-NMR spectrum) coupled with the shifted carbon signal from C-3 (at δ = 138.3 ppm in the 13 C-NMR spectrum) in the HMBC experiment, which confirms the attachment of a glucose unit to substrate 5 at C-3 (Supplementary Materials: Figure S183).
The coupling constant of a one-proton doublet from H-1 (J = 7.9 Hz) evidenced the glucose β-configuration (Supplementary Materials: Figure S171). Scheme 11. Key COSY (on the left) and HMBC (on the right) correlations for the structure elucidation of product 5d.

Biotransformation of 4 -Methylflavone (5) in the Culture of B. bassiana KCH J1.5
The biotransformation of 4 -methylflavone (5) in the culture of B. bassiana KCH J1.5 was not performed in the semi-preparative scale. The reason for this was the low conversion of the substrate during the screening procedure.
As shown above, the biotransformation of 4 -methylflavone in the culture of I. fumosorosea KCH J2 resulted in the formation of four products. It can be assumed that, at first, the reaction occurred of the hydroxylation at C-4 -CH 3 that led to 4 -hydroxymethylflavone (5a). Subsequently, three different reaction pathways occurred. The first one led to the creation of flavone 4 -methylene-O-β-D-(4 -O-methyl)-glucopyranoside (5b) after glycosylation of the newly formed hydroxyl group at C-4 -CH 3 , the second one led to the formation of flavone 4 -carboxylic acid (5c)-a product of further oxidation of the hydroxyl group at C-4 -CH 3 , and the third one ended in the formation of 4 -methylflavone 3-O-β-D-(4 -Omethyl)-glucopyranoside (5d), in which glycosylation occurred at C-3 similar to the case of 2 -methoxybiotransformation by the same fungal strain [37]. The biotransformation of 4methylflavanone in the cultures of I. fumosorosea KCH J2 resulted in the formation of similar products [46]. Scheme 12 shows the probable course of 4 -methylflavone biotransformation in the culture of I. fumosorosea KCH J2.

2 -Hydroxy-4-methylchalcone SwissADME
Pharmacokinetics, water solubility, and drug-likeness of 2 -hydroxy-4-methylchalcone and its biotransformation derivatives have been predicted using the Swiss-ADME web-site (Supplementary Materials: Figures S16, S41, S65 and S88). The Brain Or IntestinaL EstimateD permeation method (BOILED-Egg), as a predictive model that computes the lipophilicity and polarity of small molecules, showed that the gastrointestinal absorption of all tested molecules except 2 -hydroxy-4-hydroxymethylchalcone 5 -O-β-D-(4 -Omethyl)-glucopyranoside (3c) was high. The reaction of glycosylation of 2 -hydroxy-4methylchalcone observed in products 3a, 3b, and 3c resulted in increased water solubility. Biotransformation products lost the ability to permeate through the blood-brain barrier passively. However, they gained the ability to be actively transported, unlike aglycones, by the P-glycoprotein. The simulations showed a lack of inhibition of glycosylated derivatives 3a, 3b, and 3c on cytochrome P450 enzymes (CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4), which are involved in drug metabolism in human hepatocytes. These results are encouraging since the impact on CYP450 isozymes activity is responsible for adverse drug effects [47]. Molecules 3, 3a, and 3b passed Swiss-ADME platform drug-likeness estimators with zero violations. The Abbott bioavailability score (ABS), which is formulated as the probability that a compound will have >10% bioavailability in rat or measurable Caco-2 permeability, for all tested compounds was 0.55.

2 -Hydroxy-4-methylchalcone Way2Drug Pass Online
Another online tool, Way2Drug Pass Online, was used to predict biological activity, including pharmacological effects, mechanisms of action, and interaction with metabolic enzymes, of 2 -hydroxy-4-methylchalcone and its biotransformation derivatives (Supplementary Materials: Figures S17-S20 The mucomembranous protection is related to the protection of the stomach mucosa from acid gastric juices. A reported experiment with the benzimidazole derivatives linked with the pyrimidine nucleus as mucomembranous protector showed that the observed pharmacological properties confirmed computer predictions and justified their utility [48]. As demonstrated by the simulation results, the potential effect of 2 -hydroxy-4-methylchalcone (3) on the gastrointestinal tract may also be related to the carminative activity in preventing the gas formation and facilitating their excretion. Flavonoids exhibiting such activity have been used in traditional medicine [49].
Plasma membrane integrity is a key factor for cellular homeostasis [50]. Therefore, the activity of 2 -hydroxy-4-methylchalcone and 2 -hydroxy-4-methyldihydrochalcone 5 -O-β-D-(4 -O-methyl)-glucopyranoside (3a) as membrane integrity agonists should be further investigated. Our previous studies also revealed that 2 -hydroxy-4-methylchalcone (3) had a great impact on the hydrophobic area and the low impact on the hydrophilic area of the biological membrane [34].
The simulations showed that all tested compounds could exhibit anticarcinogenic activity as a monophenol monooxygenase inhibitor. A monophenol monooxygenase (tyrosinase) increased activity is associated with the development of malignant melanoma. Hence, inhibition of this enzyme may be one of the possible treatments [51][52][53].
CDP-glycerol glycerophosphotransferase is responsible for the polymerization of teichoic acid chains, which play a key role in shaping the bacterial cell, integrating its envelope, creating a bacterial biofilm, and, consequently, the pathogenesis of gram-positive bacteria [63].
The reported pharmacokinetic results and activity predictions seem encouraging as these compounds can probably be considered safe and biologically active but require further research.

4 -Methylflavone Way2Drug Pass Online
The evaluation of the biological activity of 4 -methylflavone and its biotransformation products was also made (Supplementary Materials: Figures S108-S111, S126-S129, S148-S151, S164-S167, and S186-S189).  4 -Methylflavone (5) and 4 -hydroxymethylflavone (5a) may serve as potential hypoxiainducible factor 1 (HIF-1) inhibitors. HIF-1 takes a central position in oxygen-sensing machinery. It regulates vascular development and oxygen transport in the blood system. In normal oxygen conditions in the cell, subunit HIF-1α is hydroxylated by prolyl hydroxylases (PHDs) and factor-inhibiting HIF-1 (FIH), and, consequently, degraded in the proteasome. However, under hypoxia conditions, the lack of oxygen inhibits the activity of PHDs and FIH. The unhydroxylated HIF-1α forms a complex with HIF-1β. As a result, the HIF transcription of target genes responsible for normal processes such as angiogenesis and erythropoiesis but also for carcinogenesis are activated. Hypoxia with increased HIFs activity is characteristic of malignant tumors. Therefore, inhibition of HIF-1 is one of the therapeutic targets [65,66]. Similarly, the inhibition of kinases, which take part in cellular functions, such as metabolism, cell cycle regulation, and differentiation, is used in cancer treatment because dysregulation of protein kinases is involved in carcinogenesis [67].
All tested flavones showed potential as membrane integrity agonists and membrane permeability inhibitors. The result of our previous research showed that 4 -methyflavone had an impact on the hydrophilic area of red blood cell membranes (RBCMs) and phosphatidylcholine model membranes (PC) [34]. Another team's research results with the 1,2dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) model membrane were quite similar and showed that 4 -methylflavone and 4 -methyl-7-hydroxyflavone were localized in between the hydrophilic and hydrophobic core. The interaction with the membrane followed the order flavone > 4 -methylflavone > 4 -methyl-7-hydroxyflavone > 7-hydroxyflavone [68].
The physical data, including color and form, melting point ( • C), molecular ion mass, molecular formula, retention time t R (min), retardation factor Rf, and NMR spectral data, of the resulting compounds 3 and 5 are presented below, in Tables 1-4 Table 1, 13 C-NMR, see Table 2; Supplementary Materials: Figures S1-S15.

Microorganisms
The biotransformations were performed using two entomopathogenic filamentous fungi strains, i.e., I. fumosorosea KCH J2 and B. bassiana KCH J1.5, which belong to the collection of the Department of Food Chemistry and Biocatalysis of the Wrocław University of Environmental and Life Sciences in Poland. A detailed description of the collection and reproduction of entomopathogenic filamentous fungi, as well as their genetic identification, were described in our previous papers [25,32].
HPLC analyses were performed with the use of a Dionex Ultimate 3000 instrument (Thermo Fisher Scientific, Waltham, MA, USA) with a DAD-3000 diode array detector and an analytical octadecylsilica (ODS) 2 column (4.6 × 250 mm, 5 µm particle size, Waters, Milford, MA, USA) and pre-column. The mobile phase was a mixture of 0.1% aqueous acid, formic acid v/v (A), and acetonitrile (B). The gradient program was as follows: initial conditions-32.5% B in A, 4 min-40% B in A, 8 min-40% B in A, 10 min-45% B in A, 15 min-95% B in A, 18 min-95% B in A, 19 min-32.5% B in A, 23 min-32.5% B in A. The flow rate was 1 mL min −1 , the injection volume was 5 µL, and the detection wavelengths were 254 and 280 nm. The column was operated at 30 • C. [29,30]. Data were collected with Chromeleon version 7.2 (Thermo Fisher Scientific, Waltham, MA, USA) software.
The separation of the semipreparative biotransformation products was attained with the use of 500 and 1000 µm preparative TLC silica gel plates with 10-12 µm particle size and 60 Å size of the pores (Analtech, Gehrden, Germany) with a mixture of chloroform and methanol (9:1 v/v) as the eluent. The compounds were extracted from the selected gel fractions using 20 mL ethyl acetate (Stanlab, Lublin, Poland) three times and afterward evaporated using a rotary evaporator [29,30].
The molecular formulas of all products were confirmed by analyses performed on the LC-MS 8045 SHIMADZU Triple Quadrupole Liquid Chromatograph Mass Spectrometer with an electrospray ionization (ESI) source (Shimadzu, Kyoto, Japan), as described previously with minor modifications [29,30]. The separation was achieved on the Kinetex column (2.6 µm C18 100 Å, 100 × 3 mm, Phenomenex, Torrance, CA, USA) operated at 30 • C. The mobile phase was a mixture of 0.1% aqueous formic acid v/v (A) and acetonitrile (B). The flow rate was 0.4 mL min −1 , and the injection volume was 10 µL. The gradient program was as follows: initial conditions-80% B in A, 6.5 min-100% B, 7 min-80% B in A. The principal operating parameters for the LC-MS were set as follows: nebulizing gas flow: 3 L min −1 , heating gas flow: 10 L min −1 , interface temperature: 300 • C, drying gas flow: 10 L min −1 , data acquisition range, m/z 100-500 Da; ionization mode, negative and positive. Data were collected with LabSolutions version 5.97 (Shimadzu, Kyoto, Japan) software [29,30].

Screening Procedure
The screening procedure evaluated the time needed for the complete conversion of substrates 3 and 5. The modified Sabouraud medium was utilized as a growth medium for entomopathogenic filamentous fungi (10 g aminobac (purchased from BTL, Warsaw, Poland), 30 g saccharose (purchased from Chempur, PiekaryŚląskie, Poland), 1 L distilled water). In the first step, the cultures of fungi strains were transferred from potato slants to 300 mL Erlenmeyer flasks with a 100 mL modified Sabouraud liquid medium. The cultures were bred on a rotary shaker (DHN, Warsaw, Poland) (140 rpm) at 25 • C for 72 h. In the second step, 0.5 mL of the pre-grown cultures were transferred to another 300 mL Erlenmeyer flasks with 100 mL modified Sabouraud liquid medium and also incubated at 25 • C for 72 h. Afterward, 10 mg of substrate 3 or 5 (dissolved in 0.5 mL of dimethyl sulfoxide (Chempur, PiekaryŚląskie, Poland)) was added to each flask with the microorganism. The molar concentration of substrates 3 and 5 was 0.42 mM. The samples were collected after 3, 6, and 9 days of substrate incubation and extracted with 30 mL of ethyl acetate. Subsequently, the extracts were dried for 5 min with anhydrous magnesium sulfate (Chempur, PiekaryŚląskie, Poland) and concentrated using a rotary evaporator (Heidolph, Schwabach, Germany) at 55 • C. All biotransformations were terminated after the confirmation of complete substrate conversion or lack of further substrate conversion, i.e., 9 days from the start. The collected samples were analyzed by chromatographic methods (TLC and HPLC described in 3.3) to check the composition of the post-reaction mixture. At the same time, the stability of the substrates under biotransformation conditions and the cultivation of the microorganisms without substrate were investigated as controls [29,30].

The Semipreparative Biotransformations
For each biotransformation in the semipreparative scale, a 2 L flask with 500 mL of the modified Sabouraud medium was used. The scale was adequate to obtain high enough amounts of product to perform NMR analyses and determine chemical structures.
In the first step, 1 mL of the preincubation culture of the filamentous fungi was transferred to the flask, which was subsequently incubated for 72 h under the same conditions as during the screening procedure. In the next step, 50 mg of substrate 3 or 5 (dissolved in 2.0 mL of dimethyl sulfoxide) was added to the flask. The molar concentration of substrates 3 and 5 was 0.42 mM. The incubation of the reaction mixture on the rotary shaker was continued for 9 days. The experiment was ended after the confirmation of complete substrate conversion (or lack of further substrate conversion). The flavonoid products were extracted from the post-reaction mixture 3 times with 300 mL of ethyl acetate. In the next step, the joined extracts were dried for 5 min with anhydrous magnesium sulfate, filtered, and finally dried on a rotary evaporator. The separation and purification of the microbial transformation products were achieved using preparative TLC plates. The fractions of products were marked under an ultraviolet lamp, separated, extracted (3 times with portions of 20 mL of ethyl acetate), and then analyzed by spectroscopic methods. The yields of performed biotransformations were determined based on the masses of the isolated products [29,30].

Pharmacokinetics, Drug Nature, Biological Activity Prediction
The predictions of pharmacokinetic and physicochemical properties, medicinal chemistry friendliness, and potential biological activity of flavonoid derivatives on the basis of their structural formulae were computed using the SwissADME and Way2Drug Pass Online with accompanying services (accessed date: 20 April 2022). The structures of the molecules were built by ACD Chemsketch 2021.2.0 and saved in a .mol format and in this form, imported into both programs. The biological activity types in Pass Online are shown as the probability to be revealed (Pa) and not to be revealed (Pi) and are independent values in the range from 0 to 1. The results of predictions are shown in the Supplementary Materials: Figures S16-S20, S41-S45, S65-S69, S88-S92, S125-S129, S147-S151, S163-S167, and S185-S189.

Conclusions
In the presented work, two flavonoid compounds, i.e., 2 -hydroxy-4-methylchalcone and 4 -methylflavone, were synthesized and biotransformed in the cultures of I. fumosorosea KCH J2 and B. bassiana KCH J1.5, which are two strains of entomopathogenic filamentous fungi. 2 -Hydroxy-4-methylchalcone was biotransformed in the culture of I. fumosorosea KCH J2 into two products of its glycosylation and reduction of the double bond, i.e. The simulations carried out with the use of the SwissADME platform showed that these glycoside derivatives were obtained for the first time and had an increased water solubility compared to the biotransformation substrate. Their potential biological activity predicted by the Way2Drug Pass Online tool includes antimicrobial, anticarcinogenic, chemopreventive, hepatoprotective, and membrane integrity factors.
The second tested compound, 4 -methylflavone, was successfully biotransformed only in the culture of I. fumosorosea KCH J2. The fungal enzyme system catalyzed the hydroxylation of the methyl moiety at C-4 of the flavonoid B ring to form the 4 -hydroxymethylflavone intermediate. Subsequently, the methylglucosyl moiety was attached to this hydroxyl group resulting in flavone 4 -methylene-O-β-D-(4 -O-methyl)-glucopyranoside. This strain was also able to catalyze further oxidation of 4 -hydroxymethylflavone to yield flavone 4carboxylic acid and to glycosylate 4 -hydroxymethylflavone at C-3 of the C ring to form 4 -methylflavone 3-O-β-D-(4 -O-methyl)-glucopyranoside. The two glycosylated products have not been previously described in the literature. The Swiss-ADME simulations confirmed the increased water solubility and high gastrointestinal absorption of these flavonoid derivatives. The predictions made using the Way2Drug Pass Online tool demonstrated that these compounds are, for example, potential membrane permeability inhibitors and membrane integrity agonists, vasoprotectors, and cardioprotectants. They also exhibit great potential as antiviral and antibacterial agents. Nonetheless, the actual biological activity potential and bioavailability of the obtained flavonoids need further evaluation in in vitro and in vivo tests. Our next aim is to run in vitro studies of the obtained compounds focused on their interaction with biological membranes, liposomes, and human albumin. These studies will continue our previous studies with 2 -hydroxy-4-methylchalcone, 4 -methylflavanone, and 4 -methylflavone, and will allow us to compare results for flavonoid aglycones and glycosides [34].